These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 23013035

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.
    Pierce M, O'Neill C, Felker E, Sebree T.
    Headache; 2013 Sep; 53 Suppl 2():34-42. PubMed ID: 24024601
    [Abstract] [Full Text] [Related]

  • 25. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M, Marbury T, O'Neill C, Siegel S, Du W, Sebree T.
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [Abstract] [Full Text] [Related]

  • 26. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
    Luthringer R, Djupesland PG, Sheldrake CD, Flint A, Boeijinga P, Danjou P, Demazières A, Hewson G.
    J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic evaluation of almotriptan for the treatment of migraines.
    Negro A, Lionetto L, D'Alonzo L, Casolla B, Marsibilio F, Vignaroli G, Simmaco M, Martelletti P.
    Expert Opin Drug Metab Toxicol; 2013 May; 9(5):637-44. PubMed ID: 23570251
    [Abstract] [Full Text] [Related]

  • 30. Clinical implications for breath-powered powder sumatriptan intranasal treatment.
    Tepper SJ.
    Headache; 2013 Sep; 53(8):1341-9. PubMed ID: 23809006
    [Abstract] [Full Text] [Related]

  • 31. [Sumatriptan plus naproxen for acute migraine attacks in adults].
    Schytz HW, Bendtsen L.
    Ugeskr Laeger; 2014 Aug 04; 176(32):. PubMed ID: 25292477
    [Abstract] [Full Text] [Related]

  • 32. Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding.
    Deen M, Hougaard A, Hansen HD, Schain M, Dyssegaard A, Knudsen GM, Ashina M.
    JAMA Neurol; 2019 Jul 01; 76(7):834-840. PubMed ID: 31135819
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
    Rothrock JF, Cady RK, Aurora SK, Brandes JL, Myers JA, Fox AW, Farr SJ.
    Curr Med Res Opin; 2011 Nov 01; 27(11):2185-91. PubMed ID: 21942531
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R, Ruoff G, Smith T, Barrett PS, Ames MH, Byrd S, Kori S.
    Curr Med Res Opin; 2006 Aug 01; 22(8):1535-44. PubMed ID: 16870078
    [Abstract] [Full Text] [Related]

  • 37. [New triptan preparations can help the migraine patient. Pharmacodynamic and pharmacokinetic progresses].
    Dahlöf CG.
    Lakartidningen; 1998 Nov 11; 95(46):5175, 5178-82, 5184-6. PubMed ID: 9842191
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G, Valette C.
    Rev Neurol (Paris); 2000 Jul 11; 156(6-7):646-53. PubMed ID: 10891800
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.